News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
27 Results
Type
Article (7)
Press Release (20)
Section
Business (10)
Drug Development (4)
FDA (1)
News (11)
Tag
Alliances (1)
Approvals (1)
Clinical research (2)
COVID-19 (1)
Earnings (1)
Events (1)
FDA (1)
Infectious disease (1)
Medical device (2)
Medtech (2)
People (8)
Phase 1 (2)
Phase 2 (2)
Phase 3 (1)
Preclinical (1)
Date
2023 (1)
2022 (1)
2021 (6)
2020 (1)
2019 (2)
2017 (2)
2016 (4)
2015 (5)
2014 (2)
2012 (1)
2011 (2)
Location
Asia (3)
Europe (21)
27 Results for "xeltis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Xeltis Initiates First-ever Pivotal Trial of a Synthetic Restorative Pulmonary Heart Valve
Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, announced that it has started the first-ever pivotal trial for a synthetic restorative pulmonary valve.
July 8, 2021
·
7 min read
Xeltis Closes $52M for Replacement Heart Valve Programs
The funding round was led by a global strategic investor with participation from venture capital fund Ysios Capital and a number of large private investors.
November 15, 2017
·
4 min read
Xeltis’ Technology For Natural Heart Valve Restoration Featured As The Future Of Valve Therapy At EuroPCR
May 17, 2017
·
3 min read
Xeltis Extends Series B Financing to €30 Million
December 17, 2015
·
3 min read
Xeltis Rakes In $34 Million Series B
December 2, 2014
·
3 min read
Xeltis Completes First-Ever Study Of Endogenous Tissue Growth Technology
May 19, 2015
·
3 min read
Xeltis Release: First Heart Valve That Enables Cardiovascular Restoration Successfully Implanted in Three Patients in “Xplore-I” Clinical Trial
October 3, 2016
·
3 min read
Patients Implanted With Xeltis Bioabsorbable Cardiovascular Device Showed Positive Functionality Results Two Years After Surgery - Data At EACTS
October 5, 2016
·
3 min read
Business
Innovative Cardiovascular Company Xeltis Nominates Michel Darnaud For Election To Its Board Of Directors
May 18, 2015
·
1 min read
Business
Innovative Cardiovascular Company Xeltis Nominates Michel Darnaud For Election To Its Board Of Directors
May 18, 2015
·
1 min read
1 of 3
Next
